UK markets close in 3 hours 19 minutes
  • FTSE 100

    7,019.06
    -0.47 (-0.01%)
     
  • FTSE 250

    22,603.72
    +81.54 (+0.36%)
     
  • AIM

    1,257.71
    +3.46 (+0.28%)
     
  • GBP/EUR

    1.1576
    +0.0036 (+0.32%)
     
  • GBP/USD

    1.3934
    +0.0094 (+0.68%)
     
  • BTC-GBP

    40,924.84
    +1,406.73 (+3.56%)
     
  • CMC Crypto 200

    1,293.80
    -97.91 (-7.04%)
     
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • DOW

    34,200.67
    +164.67 (+0.48%)
     
  • CRUDE OIL

    62.91
    -0.22 (-0.35%)
     
  • GOLD FUTURES

    1,782.00
    +1.80 (+0.10%)
     
  • NIKKEI 225

    29,685.37
    +2.00 (+0.01%)
     
  • HANG SENG

    29,106.15
    +136.44 (+0.47%)
     
  • DAX

    15,438.71
    -21.04 (-0.14%)
     
  • CAC 40

    6,305.01
    +17.94 (+0.29%)
     

Gouty Arthritis (Gout) - Competitive Landscape in 2021

ReportLinker
·2-min read

Summary "Gouty Arthritis (Gout) - Competitive Landscape in 2021" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gouty Arthritis (Gout) - Competitive Landscape in 2021" - https://www.reportlinker.com/p06035018/?utm_source=GNW


Solute career transporter is a major target of drug developers.There are 51 drugs in the pipeline, 94% 0f which are in early-stage.

Mid-sized Pharma companies dominates R&D in this indication. Rise in treatment-receiving population and increase in usage of more expensive branded therapies are expected to drive market growth.

This reports provides a data-driven overview of the current and future competitive landscape in gout therapeutics.

Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview

Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global gout market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global gout in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06035018/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001